Global Clinical Nutrition Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), by Infant Nutrition Type (Milk-Based, Soy-Based, Organic, Probiotic/Prebiotic, Others), By Enteral Nutrition Type (Standard, Enteral Nutrition for Chronic Illness) and By Parenteral Nutrition Type (Amino Acids, Dextrose, Fats, Additives)

With the increasing geriatric population, the clinical nutrition spends are expected to increase in the future. Due to the frail digestive framework at an old age, it becomes troublesome for human body to assimilate all the required nutrients from food. The loss of appetite is considered as a major widespread issue among the geriatric population, due to which, they do not get essential amount of nutrients.

Therefore, to get adequate supplements, the reliance of the geriatric population towards clinical nutrition support is increasing. The worldwide clinical nutrition business sector is growing because of high birth rate, increase in number of victims receiving malnutrition treatment, and high number of premature births.

GLOBAL CLINICAL NUTRITION MARKET BY PRODUCT $M (2012–2022)

On the basis of product, the global clinical nutrition market has been segmented into infant nutrition, enteral nutrition and parenteral nutrition. The various infant nutrition types include milk-based, soy-based, organic, probiotic / prebiotic and others. Enteral nutrition can be segmented into two types includes standard and enteral nutrition for chronic illness. The various parenteral nutrition types include amino acids, dextrose, fats and additives. Infant nutrition is the largest product segment in the global clinical nutrition market. In order to achieve optimal growth and development, it is recommended that infants should be breastfed for the first six month of birth. Also, it is necessary to provide an infant with the optimal amount of nutrients, which are necessary during the first three years of a baby’s life for proper health and wellbeing. The infant nutrition products are required to meet these nutritional requirements. During the initial phase of an infant’s life, any deficit can lead to developmental retardation, growth retardation, and increased risk of infection, blindness, and anemia. The importance of providing infant nutrition increases manifold in the premature birth cases. Generally, nations with high birth rate are expected to witness more incidents of premature births. Health-wise, premature birth usually leads to long-term adverse consequences. Prematurely born children are at a greater risk to fall victim to sensory deficit, cerebral palsy, learning disabilities, and respiratory illnesses, as compared to children born at the end of a normal term. When mothers are not able to/choose not to breastfeed their babies, due to illness or other reasons, infant formulas make for suitable alternatives. Infant formula products are widely available at supermarkets and through other retail channels.

Enteral nutrition is a type of nourishment that is transmitted specifically into the digestive arrangement of a person, in form of fluid. Tube feeding is the most widely recognized type of enteral nutrition. Tube feeding can be given to individuals, who are not ready to meet their wholesome needs, with food and beverages, and are not vulnerable to go through uncontrollable vomiting, or looseness of the bowels.

Parenteral nutrition can be given to those patients whose daily nutritional requirement cannot be met through the normal digestive pathway, while they are not able to eat, digest and consume nutrients. Parenteral nutrition refers to intravenous feeding and delivery of nutrients in form of a solution that is directly infused into the bloodstream, through a special catheter and tubing.

The global clinical nutrition market was valued at $39,339.4 million in 2015, and it is expected to grow at a CAGR of 5.4% during 2016-2022. The increasing geriatric population, high birth rate and high number of premature birth, surge in the number of victims of malnutrition receiving treatment, escalating incidence of lifestyle associated disease, and increasing incidence of cancer and central nervous system diseases are driving the growth of the clinical nutrition market.

Asia-Pacific accounted for the largest share (40.4%) in the global clinical nutrition market. The region is anticipated to witness rapid growth during the forecast period. The increasing birth rate, along with growing geriatric population and high number of people with malnutrition is driving the growth of the clinical nutrition market in the region.

Some of the major players operating in the global clinical nutrition market include Baxter International Inc., Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, and Perrigo Company Plc.